Acoustic Wave Sensor Detection of an Ovarian Cancer Biomarker with Antifouling Surface Chemistry

Overview

Journal Sensors (Basel)

Publisher MDPI

Specialty Biotechnology

Date 2025 Jan 8

PMID 39771624

Authors

Katharina Davoudian

Sandro Spagnolo

Edmund Chan

Tibor Hianik

Michael Thompson

Affiliations

Soon will be listed here.

Abstract

Ovarian cancer (OC) must be detected in its early stages when the mortality rate is the lowest to provide patients with the best chance of survival. Lysophosphatidic acid (LPA) is a critical OC biomarker since its levels are elevated across all stages and increase with disease progression. This paper presents an LPA assay based on a thickness shear mode acoustic sensor with dissipation monitoring that involves a new thiol molecule 3-(2-mercaptoethanoxy)propanoic acid (HS-MEG-COOH). HS-MEG-COOH is an antifouling linker that provides (a) antifouling properties for gold substrates and (b) linking ability via its terminal carboxylic acid functional group. The antifouling ability of HS-MEG-COOH was tested in whole human serum. The new molecule was applied to the LPA assay in conjunction with a spacer molecule, 2-(2-mercaptoethoxy)ethan-1-ol (HS-MEG-OH), in a 1:1 / ratio. HS-MEG-COOH was covalently linked to gelsolin-actin, a protein complex probe that dissociates due to LPA-binding. LPA was detected in phosphate-buffered saline and undiluted human serum and achieved a low limit of detection (1.0 and 0.7 μM, respectively) which was below the concentration of LPA in healthy individuals. The antifouling properties of HS-MEG-COOH and the detection of LPA demonstrate the ability of the sensor to successfully identify the early-stage OC biomarker in undiluted human serum.

References

Armbruster D, Pry T . Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev. 2008; 29 Suppl 1:S49-52. PMC: 2556583. View

Lichtenberg J, Ling Y, Kim S . Non-Specific Adsorption Reduction Methods in Biosensing. Sensors (Basel). 2019; 19(11). PMC: 6603772. DOI: 10.3390/s19112488. View

Spagnolo S, Franier B, Hianik T, Thompson M . Surface Probe Linker with Tandem Anti-Fouling Properties for Application in Biosensor Technology. Biosensors (Basel). 2020; 10(3). PMC: 7146171. DOI: 10.3390/bios10030020. View

Onen O, Ahmad A, Guldiken R, Gallant N . Surface modification on acoustic wave biosensors for enhanced specificity. Sensors (Basel). 2012; 12(9):12317-28. PMC: 3478841. DOI: 10.3390/s120912317. View

Feldt J, Schicht M, Garreis F, Welss J, Schneider U, Paulsen F . Structure, regulation and related diseases of the actin-binding protein gelsolin. Expert Rev Mol Med. 2019; 20:e7. DOI: 10.1017/erm.2018.7. View

Hurwitz L, Pinsky P, Trabert B . General population screening for ovarian cancer. Lancet. 2021; 397(10290):2128-2130. DOI: 10.1016/S0140-6736(21)01061-8. View

Zhang R, Siu M, Ngan H, Chan K . Molecular Biomarkers for the Early Detection of Ovarian Cancer. Int J Mol Sci. 2022; 23(19). PMC: 9569881. DOI: 10.3390/ijms231912041. View

Klepel F, Ravoo B . Dynamic covalent chemistry in aqueous solution by photoinduced radical disulfide metathesis. Org Biomol Chem. 2017; 15(18):3840-3842. DOI: 10.1039/c7ob00667e. View

Franier B, Thompson M . Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum. Biosensors (Basel). 2020; 10(2). PMC: 7168251. DOI: 10.3390/bios10020013. View

10.

Davoudian K, Spagnolo S, Lotay N, Satkauskas M, Meszaros G, Hianik T . Design and Characterization of a Dual-Protein Strategy for an Early-Stage Assay of Ovarian Cancer Biomarker Lysophosphatidic Acid. Biosensors (Basel). 2024; 14(6). PMC: 11201771. DOI: 10.3390/bios14060287. View

11.

Romito O, Lemettre A, Chantome A, Champion O, Couty N, Ouldamer L . Plasma membrane SK2 channel activity regulates migration and chemosensitivity of high-grade serous ovarian cancer cells. Mol Oncol. 2024; 18(8):1853-1865. PMC: 11306528. DOI: 10.1002/1878-0261.13631. View

12.

Avci C, Sheikh S, Blaszykowski C, Thompson M . Critical role of surface hydration on the dynamics of serum adsorption studied with monoethylene glycol adlayers on gold. Chem Commun (Camb). 2012; 49(5):466-8. DOI: 10.1039/c2cc37477c. View

13.

Ahmadi S, Lotay N, Thompson M . Affinity-based electrochemical biosensor with antifouling properties for detection of lysophosphatidic acid, a promising early-stage ovarian cancer biomarker. Bioelectrochemistry. 2023; 153:108466. DOI: 10.1016/j.bioelechem.2023.108466. View

14.

Sedlakova I, Vavrova J, Tosner J, Hanousek L . Lysophosphatidic acid (LPA)—a perspective marker in ovarian cancer. Tumour Biol. 2010; 32(2):311-6. DOI: 10.1007/s13277-010-0123-8. View

15.

Fischerova D, Burgetova A . Imaging techniques for the evaluation of ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2014; 28(5):697-720. DOI: 10.1016/j.bpobgyn.2014.04.006. View

16.

Mohaghegh P, Rockall A . Imaging strategy for early ovarian cancer: characterization of adnexal masses with conventional and advanced imaging techniques. Radiographics. 2012; 32(6):1751-73. DOI: 10.1148/rg.326125520. View

17.

Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A . Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009; 10(4):327-40. DOI: 10.1016/S1470-2045(09)70026-9. View

18.

Zhang R, Liu Y, He M, Su Y, Zhao X, Elimelech M . Antifouling membranes for sustainable water purification: strategies and mechanisms. Chem Soc Rev. 2016; 45(21):5888-5924. DOI: 10.1039/c5cs00579e. View

19.

Xu X, Hu J, Xue H, Hu Y, Liu Y, Lin G . Applications of human and bovine serum albumins in biomedical engineering: A review. Int J Biol Macromol. 2023; 253(Pt 3):126914. DOI: 10.1016/j.ijbiomac.2023.126914. View

20.

von der Ecken J, Muller M, Lehman W, Manstein D, Penczek P, Raunser S . Structure of the F-actin-tropomyosin complex. Nature. 2014; 519(7541):114-7. PMC: 4477711. DOI: 10.1038/nature14033. View